Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne W Chiu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Human Vaccines & Immunotherapeutics|July 12, 2016
Pembrolizumab (Keytruda)Gerry Kwok, Thomas C C Yau, Joanne W Chiu, et al.
Investigational New Drugs|May 5, 2015
Pharmacokinetic assessment of dacomitinib (pan-HER tyrosine kinase inhibitor) in patients with locally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through a gastrostomy feeding tube (GT)Joanne W Chiu, Kelvin Chan, Eric X Chen, et al.
The Oncologist|August 14, 2014
Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapyJoanne W Chiu, Hilda Wong, Roland Leung, et al.
Advances in Therapy|October 26, 2021
Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast CancersBryan Li, Thomas Yau, Roland Leung, et al.
Postgraduate Medical Journal|April 21, 2019
Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapyJoanne W Chiu, Roland Leung, Vikki Tang, et al.
Investigational New Drugs|December 22, 2015
A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)Joanne W Chiu, Sebastien J Hotte, Christian K Kollmannsberger, et al.
Clinical Colorectal Cancer|November 13, 2017
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre ExperienceJoanne W Chiu, Monika K Krzyzanowska, Stefano Serra, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Human Vaccines & Immunotherapeutics|July 12, 2016
Pembrolizumab (Keytruda)Gerry Kwok, Thomas C C Yau, Joanne W Chiu, et al.
Investigational New Drugs|May 5, 2015
Pharmacokinetic assessment of dacomitinib (pan-HER tyrosine kinase inhibitor) in patients with locally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through a gastrostomy feeding tube (GT)Joanne W Chiu, Kelvin Chan, Eric X Chen, et al.
The Oncologist|August 14, 2014
Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapyJoanne W Chiu, Hilda Wong, Roland Leung, et al.
Advances in Therapy|October 26, 2021
Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast CancersBryan Li, Thomas Yau, Roland Leung, et al.
Postgraduate Medical Journal|April 21, 2019
Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapyJoanne W Chiu, Roland Leung, Vikki Tang, et al.
Investigational New Drugs|December 22, 2015
A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)Joanne W Chiu, Sebastien J Hotte, Christian K Kollmannsberger, et al.
Clinical Colorectal Cancer|November 13, 2017
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre ExperienceJoanne W Chiu, Monika K Krzyzanowska, Stefano Serra, et al.
Pageof 1